Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025 ...

Picked up a ball in the middle of the pitch and drew the challenge from a Stevenage player, nearing the man a booking. Came ...

- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to have dosed 30 participants in total by early 2026, then plans to meet with ...

Ben Shapiro, the conservative podcast host, also condemned Mr. Carlson on Monday as “the most virulent superspreader of vile ...

Online romance has migrated from actual dating apps to… everywhere else. Here we break down the romantic potential of the ...

There is no evidence that less frequent financial reporting impairs company performance, market functioning, or the quality of investor information.

Peer-reviewed study in Cell Reports Medicine demonstrates that N17350 delivers selective, immune-activating tumor killing across solid tumor types -- N17350 targets a cancer vulnerability, via the ...

Anika Therapeutics, Inc. (NASDAQ: ANIK) Q3 2025 Earnings Call Transcript November 5, 2025 Anika Therapeutics, Inc. misses on ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” third-quarter 2025 investor letter. A copy ...

Gardening offers a sensory, rhythmic way to calm the nervous system, lift mood, and retrain the brain, helping us heal anxiety and depression from the ground up.

A federal judge in Oregon has once again barred President Donald Trump’s administration from deploying the National Guard to ...

AXPAXLI™ (also known as OTX-TKI) is an investigational, bioresorbable, intravitreal hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase inhibitor with anti-angiogenic ...